181 related articles for article (PubMed ID: 6762138)
21. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
[TBL] [Abstract][Full Text] [Related]
22. The effect of pregnancy and two different contraceptive pills on serum lipids and lipoproteins in a woman with a type III hyperlipoproteinaemia pattern.
Muller DP; Pavlou C; Whitelaw AG; McLintock D
Br J Obstet Gynaecol; 1978 Feb; 85(2):127-33. PubMed ID: 626721
[TBL] [Abstract][Full Text] [Related]
23. Metabolic effects of two triphasic formulations containing ethinyl estradiol and dl-norgestrel.
Smith RP; Sizto R
Contraception; 1983 Aug; 28(2):189-99. PubMed ID: 6641221
[TBL] [Abstract][Full Text] [Related]
24. Effects of desogestrel on carbohydrate metabolism.
Shoupe D
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 2):1041-7. PubMed ID: 8447358
[TBL] [Abstract][Full Text] [Related]
25. The role of triphasic levonorgestrel in oral contraception: a review of metabolic and hemostatic effects.
Lachnit-Fixson U
Gynecol Endocrinol; 1996 Jun; 10(3):207-18. PubMed ID: 8862497
[TBL] [Abstract][Full Text] [Related]
26. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
27. Effects of oral contraceptives on carbohydrate metabolism.
Wynn V; Godsland I
J Reprod Med; 1986 Sep; 31(9 Suppl):892-7. PubMed ID: 3095547
[TBL] [Abstract][Full Text] [Related]
28. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
[TBL] [Abstract][Full Text] [Related]
29. Glucose and lipid metabolism with triphasic oral contraceptives in women with history of gestational diabetes.
Kung AW; Ma JT; Wong VC; Li DF; Ng MM; Wang CC; Lam KS; Young RT; Ma HK
Contraception; 1987 Mar; 35(3):257-69. PubMed ID: 3111786
[TBL] [Abstract][Full Text] [Related]
30. The effect of obesity and low-dose oral contraceptives on carbohydrate and lipid metabolism.
Beasley A; Estes C; Guerrero J; Westhoff C
Contraception; 2012 May; 85(5):446-52. PubMed ID: 22078632
[TBL] [Abstract][Full Text] [Related]
31. [Metabolic risks of oral contraception].
Monier L
Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
[TBL] [Abstract][Full Text] [Related]
32. Hormonal contraceptives and carbohydrate tolerance. II. Influence of medroxyprogesterone acetate and chronic oral contraceptives.
Vermeulen A; Thiery M
Diabetologia; 1974 Aug; 10(4):253-9. PubMed ID: 4213146
[TBL] [Abstract][Full Text] [Related]
33. Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study.
Kjos SL; Shoupe D; Douyan S; Friedman RL; Bernstein GS; Mestman JH; Mishell DR
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1822-7. PubMed ID: 2256489
[TBL] [Abstract][Full Text] [Related]
34. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
Crook D; Godsland IF; Wynn V
Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of the metabolic effects of injectable and oral contraceptives.
Liew DF; Ng CS; Heng SH; Ratnam SS
Contraception; 1986 Apr; 33(4):385-94. PubMed ID: 2942334
[TBL] [Abstract][Full Text] [Related]
36. Plasma glucose and insulin levels in women using a levonorgestrel-containing triphasic oral contraceptive for three months.
Spellacy WN; Ellingson AB; Kotlik A; Tsibris JC
Contraception; 1988 Jul; 38(1):27-35. PubMed ID: 3139358
[TBL] [Abstract][Full Text] [Related]
37. A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel.
Janaud A; Rouffy J; Upmalis D; Dain MP
Acta Obstet Gynecol Scand Suppl; 1992; 156():33-8. PubMed ID: 1324555
[TBL] [Abstract][Full Text] [Related]
38. The metabolic impact of oral contraceptives.
Krauss RM; Burkman RT
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
[TBL] [Abstract][Full Text] [Related]
39. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
Akerlund M; Almström E; Högstedt S; Nabrink M
Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
[TBL] [Abstract][Full Text] [Related]
40. Effect of seven low-dose combined oral contraceptive preparations on carbohydrate metabolism.
van der Vange N; Kloosterboer HJ; Haspels AA
Am J Obstet Gynecol; 1987 Apr; 156(4):918-22. PubMed ID: 3578401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
